Tranexamic acid and Isosorbide mononitrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tranexamic acid (tranexamic acid) and Isosorbide mononitrate (isosorbide mononitrate). Common drug interactions include chronic kidney disease among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Tranexamic acid and Isosorbide mononitrate. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Tranexamic acid?

Tranexamic acid has active ingredients of tranexamic acid. It is often used in heavy or prolong menstrual bleeding. eHealthMe is studying from 8,687 Tranexamic acid users. Check the latest studies of Tranexamic acid.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.



On Jul, 27, 2026

18 people who take Tranexamic acid and Isosorbide mononitrate together, and have interactions are studied.

Tranexamic acid and Isosorbide mononitrate drug interactions.

What are the common drug interactions of Tranexamic Acid and Isosorbide Mononitrate, by gender? *:

female:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Renal failure (kidney dysfunction)
  4. Arthralgia (joint pain)
  5. Haemoglobin decreased
  6. Oropharyngeal blistering (blister of oropharynx)
  7. Purpura (purplish discoloration of the skin)
  8. Rash erythematous (redness of the skin)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Rectal haemorrhage (bleeding from anus)

male:

  1. Pneumonia
  2. Blood creatinine increased
  3. Blood potassium increased
  4. Blood pressure decreased
  5. Chronic kidney disease
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Heart rate increased
  8. Hepatocellular damage (liver damage)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Pyrexia (fever)

What are the common drug interactions of Tranexamic Acid and Isosorbide Mononitrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Haemoglobin decreased
  3. Oropharyngeal blistering (blister of oropharynx)
  4. Purpura (purplish discoloration of the skin)
  5. Rash erythematous (redness of the skin)
  6. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  7. Rectal haemorrhage (bleeding from anus)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Vaginal haemorrhage (vaginal bleeding)

40-49:

n/a

50-59:

n/a

60+:

  1. Pneumonia
  2. Blood creatinine increased
  3. Pyrexia (fever)
  4. Death
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Lung infection
  7. Blood chloride decreased
  8. Blood potassium increased
  9. Blood pressure decreased
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 38.89%
  2. High Blood Pressure: 4 people, 22.22%
  3. High Blood Cholesterol: 3 people, 16.67%
  4. Dyspnea (difficult or laboured breathing): 3 people, 16.67%
  5. Gout (uric acid crystals building up in the body): 3 people, 16.67%
  6. Depression: 3 people, 16.67%
  7. Pain: 3 people, 16.67%
  8. Constipation: 3 people, 16.67%
  9. Insomnia (sleeplessness): 3 people, 16.67%
  10. Itching: 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tranexamic acid and Isosorbide mononitrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tranexamic acid and Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tranexamic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tranexamic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tranexamic acid and isosorbide mononitrate (the active ingredients of Tranexamic acid and Isosorbide mononitrate, respectively), and Tranexamic acid and Isosorbide mononitrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: